Viewing Study NCT04939402


Ignite Creation Date: 2025-12-25 @ 3:39 AM
Ignite Modification Date: 2026-01-09 @ 5:59 PM
Study NCT ID: NCT04939402
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-18
First Post: 2021-04-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the UZ Brussel Following COVID-19 Vaccination Using an Adenoviral Vector
Sponsor: Universitair Ziekenhuis Brussel
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module